Former Turing Pharmaceuticals CEO Martin Shkreli is interviewed by host Maria Bartiromo during her ‘Mornings with Maria Bartiromo‘ program on the Fox Business Network, in New York, Tuesday, Feb. 2, 2016.Richard Drew/The Associated Press
Former pharmaceutical CEO Martin Shkreli says he'd like to "berate" and "insult" Congress – but instead will take the Fifth Amendment during questioning on Thursday.
The former Turing Pharmaceuticals CEO, who's reviled for hiking the price of a lifesaving drug, spoke Tuesday on Fox Business.
Shkreli said that instead of invoking his right against self-incrimination, as planned, he would "love to talk to Congress." He says he would "berate them" and "insult them."
Meanwhile, his new lawyer, Benjamin Brafman, issued a statement expressing confidence that Shkreli will be exonerated in his federal court case. He'll have a routine court appearance Wednesday in New York.
In December, the former hedge fund manager was charged with securities fraud and conspiracy related to another pharmaceutical company he previously ran, Retrophin.